RESEARCHER PROFILE
Maheen Rizwan
← Back to Fatima Jinnah Medical University
M
Fatima Jinnah Medical University
Maheen Rizwan works in Global Cancer Incidence and Screening, Coronary Interventions and Diagnostics, Heart Failure Treatment and Management, Prostate Cancer Diagnosis and Treatment, Acute Myocardial Infarction Research. Recorded institutional associations include Fatima Jinnah Medical University, Allama Iqbal Medical College.
20Publications
0Citations
0H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Considering Real-World Effectiveness of GLP-1RA Persistence and Outcomes for Weight loss regimes.
2025 · 0 citationsMethodological Considerations in Assessing Coronary Flow Reserve After Percutaneous Coronary Intervention
2025 · 0 citationsEmergency Leaflet Perforation: A Provocative Concept Requiring Further Study
2025 · 0 citationsConcerns regarding matching and long-term risk assessment in living kidney donor outcome studies
2025 · 0 citationsMethodological Considerations in TG/HDL Ratio and Cognitive Function in Older Adults
2025 · 0 citationsRe‐Examining the Clinical Significance of CT ‐Detected Appendiceal Fecoliths: Methodological Considerations
2025 · 0 citationsBeyond Aspirin: Reevaluating Rivaroxaban-Clopidogrel Therapy in PCI Patients with Gastrointestinal Disease
2026 · 0 citations26-A-15034-ACC COMPARATIVE EFFICACY AND SAFETY OF SIROLIMUS- AND BIOLIMUS-COATED BALLOONS VERSUS PACLITAXEL-COATED BALLOONS IN CORONARY ARTERY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANGIOGRAPHIC AND CLINICAL OUTCOMES FROM RANDOMIZED CONTROLLED TRIALS
2026 · 0 citationsD-94 | Comparative efficacy of levosimendan versus milrinone in adults with pulmonary hypertension: a systematic review and meta-analysis
2026 · 0 citationsB-88 | Comparative Efficacy of Levosimendan Versus Milrinone in Adults with Pulmonary Hypertension: A Systematic Review and Meta-Analysis
2026 · 0 citationsThe efficacy of adjuvant chemoendocrine versus endocrine therapy alone in hormone receptor-positive, HER2-negative early breast cancer: A meta-analysis of reconstructed individual patient data.
2026 · 0 citationsTrends in mortality from unspecified malignant neoplasm of the liver among U.S. adults aged ≥45 years, 1999–2023.
2026 · 0 citationsTemporal trends in mortality involving esophageal cancer with comorbid psychoactive substance-induced mood disorders among adults aged ≥55 years in the United States, 1999–2023: A retrospective CDC WONDER analysis.
2026 · 0 citationsTrends and disparities in prostate cancer mortality among men with hypertension in the United States: A CDC WONDER analysis (1999–2020).
2026 · 0 citationsEfficacy of angiotensin receptor–neprilysin inhibitor (ARNI) for prevention of cancer therapy–related cardiac dysfunction: A meta-analysis of randomized controlled trials.
2026 · 0 citationsNational trends in mortality from gastric cancer with metastatic involvement of the digestive and respiratory systems in the United States.
2026 · 0 citationsTrends in leukemia-related mortality with heart failure as a contributing cause among U.S. adults aged ≥55 years, 1999–2023.
2026 · 0 citationsTrends and disparities in prostate cancer and tobacco use–related mortality among adults aged ≥55 years in the United States, 1999-2024: A CDC WONDER analysis.
2026 · 0 citationsMortality trend from multiple myeloma with hypertensive diseases as a contributing cause in the United States, 1999–2024: A CDC WONDER analysis across age, sex, and geographic variables.
2026 · 0 citationsMortality trends and demographic disparities in breast cancer deaths with co-existing diabetes mellitus among U.S. adults ≥45 years, 1999–2020.
2026 · 0 citations
